MELISSA KELLY Insider Trading $GERN GERON CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MELISSA KELLY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MELISSA KELLY. MELISSA KELLY is EVP BD and Port&Alliance Mgmt in GERON CORP ($GERN) and EVP BD, Port & Alliance Mgmt in GERON CORP ($GERN) and EVP Chief Business Officer in GERON CORP ($GERN) and EVP Portfolio & Alliance Mgmt in GERON CORP ($GERN) and EVP, BD, Port & Alliance Mgmt in GERON CORP ($GERN) and EVP, Chief Business Officer in GERON CORP ($GERN) and VP, Oncology in GERON CORP ($GERN).
MELISSA KELLY in GERON CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MELISSA KELLY: EVP, Chief Business Officer, EVP Chief Business Officer, EVP Portfolio & Alliance Mgmt, EVP BD, Port & Alliance Mgmt, EVP, BD, Port & Alliance Mgmt, EVP BD and Port&Alliance Mgmt, VP, Oncology
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 04 2021
$GERN Market Capitalization: $331.02M
$GERN Previous Close: $2.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MELISSA KELLY in GERON CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2021 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP, Chief Business ... | Option Exercise | A | 2.06 | 300,000 | 616,500 | 300,000 | |
| Feb 14 2020 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP, Chief Business ... | Option Exercise | A | 1.30 | 291,375 | 377,331 | 291,375 | |
| Apr 10 2019 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP, Chief Business ... | Sell | S | 2.00 | 120,635 | 241,270 | 0 | 120.6 K to 0 (-100.00 %) |
| Feb 01 2019 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP Chief Business ... | Option Exercise | A | 1.03 | 300,000 | 309,000 | 300,000 | |
| Feb 02 2018 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP Portfolio & All ... | Option Exercise | A | 2.45 | 300,000 | 735,000 | 300,000 | |
| Feb 10 2017 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP BD, Port & Alli ... | Option Exercise | A | 2.15 | 300,000 | 645,000 | 300,000 | |
| Feb 12 2016 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP, BD, Port & All ... | Option Exercise | A | 2.54 | 210,000 | 533,400 | 210,000 | |
| Jun 01 2015 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP BD and Port&All ... | Sell | S | 3.84 | 2,380 | 9,139 | 120,635 | 123 K to 120.6 K (-1.93 %) |
| Mar 16 2015 | GERN | GERON CORP | BEHRS MELISSA KELLY | EVP BD and Port&All ... | Option Exercise | A | 4.34 | 210,000 | 911,400 | 210,000 | |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Option Exercise | M | 5.08 | 19,532 | 99,223 | 246,096 | |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Option Exercise | M | 3.76 | 46,039 | 173,107 | 265,628 | |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Sell | S | 10.88 | 19,532 | 212,508 | 5,716 | 25.2 K to 5.7 K (-77.36 %) |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Sell | S | 10.88 | 46,039 | 500,904 | 25,248 | 71.3 K to 25.2 K (-64.58 %) |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Buy | M | 5.08 | 19,532 | 99,223 | 71,287 | 51.8 K to 71.3 K (+37.74 %) |
| Aug 01 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Buy | M | 3.76 | 46,039 | 173,107 | 51,755 | 5.7 K to 51.8 K (+805.44 %) |
| May 10 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Option Exercise | A | 6.40 | 60,000 | 384,000 | 311,667 | |
| Jan 14 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Sell | S | 8.57 | 8,648 | 74,113 | 5,716 | 14.4 K to 5.7 K (-60.21 %) |
| Jan 14 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Grant | A | 0.00 | 8,648 | 0 | 14,364 | 5.7 K to 14.4 K (+151.29 %) |
| Jan 14 2005 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Buy | I | 8.83 | 1,472 | 12,998 | 5,716 | 4.2 K to 5.7 K (+34.68 %) |
| Jun 01 2004 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Option Exercise | A | 7.56 | 37,500 | 283,500 | 251,667 | |
| Apr 07 2004 | GERN | GERON CORP | KELLY MELISSA | VP, Oncology | Sell | S | 9.60 | 2,029 | 19,478 | 4,244 | 6.3 K to 4.2 K (-32.34 %) |
Page: 1